Multimodal optical imaging platform for the early diagnosis for oral neoplasia
July 23-26, 2017
Early diagnosis is critical to reducing the global burden of oral cancer. In the US, 65% of oral cancer patients are diagnosed after regional metastasis; these patients have a 50% five-year mortality compared to 17% for those with localized disease. A major reason for late diagnosis is that clinicians are unable to accurately distinguish neoplastic lesions, which require treatment, from benign lesions. Furthermore, clinicians are unable to accurately select to biopsy the site with the worst diagnosis within a larger lesion.
Please download the file below for full content.
Eric Yang, Nadarajah Vigneswaran, Ann Gillenwater, and Rebecca Richards-Kortum, "Multimodal optical imaging platform for the early diagnosis for oral neoplasia" in "Advances in Optics for Biotechnology, Medicine and Surgery XV", Peter So, Massachusetts Institute of Technology, USA Kate Bechtel, Triple Ring Technologies, USA Ivo Vellekoop, University of Twente, The Netherlands Michael Choma, Yale University, USA Eds, ECI Symposium Series, (2017). http://dc.engconfintl.org/biotech_med_xv/1
This document is currently not available here.